Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Rafik Mark Ghobrial"'
Autor:
Elizabeth W. Brombosz, Linda W. Moore, Constance M. Mobley, Sudha Kodali, Ashish Saharia, Mark J. Hobeika, Ashton A. Connor, David W. Victor, Yee Lee Cheah, Caroline J. Simon, Ahmed Osama Gaber, Rafik Mark Ghobrial
Publikováno v:
Frontiers in Transplantation, Vol 2 (2023)
BackgroundLiver retransplantation (reLT) has historically had inferior survival relative to primary liver transplant (LT). To improve outcomes after reLT, researchers have identified factors predicting overall (OS) and/or graft survival (GS) after re
Externí odkaz:
https://doaj.org/article/d6b0ca54f4544a6fbda1dc1abbd4463a
Autor:
Ashton A. Connor, MD, PhD, Howard J. Huang, MD, Constance M. Mobley, MD, PhD, Edward A. Graviss, MD, Duc T. Nguyen, MD, PhD, Ahmad Goodarzi, MD, Ashish Saharia, MD, Simon Yau, MD, Mark J. Hobeika, MD, Erik E. Suarez, MD, Mozhgon Moaddab, PharmD, Elizabeth W. Brombosz, PhD, Linda W. Moore, PhD, Stephanie G. Yi, MD, A. Osama Gaber, MD, Rafik Mark Ghobrial, MD, PhD
Publikováno v:
Transplantation Direct, Vol 9, Iss 5, p e1482 (2023)
Background. Combined liver–lung transplantation is an uncommon, although vital, procedure for patients with simultaneous end-stage lung and liver disease. The utility of lung–liver transplant has been questioned because of initial poor survival o
Externí odkaz:
https://doaj.org/article/a42d801093754a2fb0ebbf1b3d8cce55
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 1, p 216 (2020)
The development, progression, or stabilization of the atherosclerotic plaque depends on the pro-inflammatory and anti-inflammatory macrophages. The influx of the macrophages and the regulation of macrophage phenotype, inflammatory or anti-inflammator
Externí odkaz:
https://doaj.org/article/19c57218be414cfb9240a5289a648878
Publikováno v:
Biochemistry Research International, Vol 2012 (2012)
Externí odkaz:
https://doaj.org/article/75de056043214c15b4a4d1886bb548a8
Autor:
Jennifer L. Alejo, Jonathan Mitchell, Teresa P.-Y. Chiang, Amy Chang, Aura T. Abedon, William A. Werbel, Brian J. Boyarsky, Laura B. Zeiser, Robin K. Avery, Aaron A.R. Tobian, Macey L. Levan, Daniel S. Warren, Allan B. Massie, Linda W. Moore, Ashrith Guha, Howard J. Huang, Richard J. Knight, Ahmed Osama Gaber, Rafik Mark Ghobrial, Jacqueline M. Garonzik-Wang, Dorry L. Segev, Sunjae Bae
Publikováno v:
Transplantation. 106:e452-e460
Solid organ transplant recipients (SOTRs) are less likely to mount an antibody response to SARS-CoV-2 mRNA vaccines. Understanding risk factors for impaired vaccine response can guide strategies for antibody testing and additional vaccine dose recomm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8704f3fcf31b0eb94d70e2e01267db8
https://doi.org/10.1097/tp.0000000000004259
https://doi.org/10.1097/tp.0000000000004259
Autor:
Maen Abdelrahim, Abdullah Esmail, Ashish Saharia, Ala Abudayyeh, Noha Abdel-Wahab, Adi Diab, Naoka Murakami, Ahmed O. Kaseb, Jenny C. Chang, Ahmed Osama Gaber, Rafik Mark Ghobrial
Publikováno v:
Cancers. 14(7)
Hepatocellular carcinoma (HCC) represents the second most common cause of cancer-related deaths and accounts for over eighty percent of primary liver cancers worldwide. Surgical resection and radiofrequency ablation in small tumors are included in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10a54d8a2f6a24c5b1ea2314840b9be7
https://pubmed.ncbi.nlm.nih.gov/35406533
https://pubmed.ncbi.nlm.nih.gov/35406533
Autor:
Maen Abdelrahim, Abdullah Esmail, Ashish Saharia, Robert McMillan, Aiwu Ruth He, Jason S. Starr, Harmeet Dhani, Vasily N. Aushev, Allyson Koyen Malashevich, Nicole Hook Rattigan, Phil Gauthier, Adham Jarudi, Rafik Mark Ghobrial
Publikováno v:
Journal of Clinical Oncology. 40:e16123-e16123
e16123 Background: Hepatocellular carcinoma (HCC) is an aggressive malignancy for which liver transplantation can be curative. Unfortunately, ̃8-20% of HCC patients will go on to relapse post-transplantation. Personalized and tumor-informed circulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e5c8826b4c529552f67632cb3e1e8d7
https://doi.org/10.1200/jco.2022.40.16_suppl.e16123
https://doi.org/10.1200/jco.2022.40.16_suppl.e16123
Autor:
Maen Abdelrahim, Abdullah Esmail, Jiaqiong Xu, Godsfavour Umoru, Ashish Saharia, Robert McMillan, Rafik Mark Ghobrial
Publikováno v:
Journal of Clinical Oncology. 40:e16202-e16202
e16202 Background: Cholangiocarcinoma (CCA)management is constantly being updated in view of existing evidence in order to establish practice guidelines and consensus statements. Here, we evaluate and compare the potential efficacy of chemotherapy co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::436eec1438a6e94ec06916aeae522bee
https://doi.org/10.1200/jco.2022.40.16_suppl.e16202
https://doi.org/10.1200/jco.2022.40.16_suppl.e16202
Autor:
Abdullah Esmail, David Victor, Sudha Kodali, Edward A. Graviss, Duc T. Nguyen, Linda W. Moore, Ashish Saharia, Robert McMillan, Joy N. Fong, Ahmed Uosef, Mahmoud Elshawwaf, Kirk Heyne, Rafik Mark Ghobrial, Maen Abdelrahim
Publikováno v:
Journal of Clinical Oncology. 40:e16201-e16201
e16201 Background: Hepatocellular carcinoma (HCC) is the world's sixth most prevalent cancer and the third leading cause of cancer-related death. For patients with advanced HCC, trials combining TACE with tyrosine kinase inhibitors (TKIs) such as Sor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a814d8d7925c4f32fc0ddd0a863209d3
https://doi.org/10.1200/jco.2022.40.16_suppl.e16201
https://doi.org/10.1200/jco.2022.40.16_suppl.e16201
Publikováno v:
Cancers, Vol 14, Iss 743, p 743 (2022)
Transplant oncology is an emerging field in cancer treatment that applies transplant medicine, surgery, and oncology to improve cancer patient survival and quality of life. A critical concept that must be addressed to ensure the successful applicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34bcc5cba1e535e62b9850017844dc03
https://doi.org/10.3390/cancers14030743
https://doi.org/10.3390/cancers14030743